March 21 (Reuters) - 3D Signatures Inc DXD.V :
* 3D Signatures- clinical study results say based on swab from a patient's cheek, its proprietary Teloview software platform can identify Alzheimer's disease Source text for Eikon: ID:nGNXNQWQKa Further company coverage: DXD.V